$PFE and $MYL

What are we thinking, this deal is worth ~$2.17 in cash and $2-3 of Viatris stock when the dust settles in the new year?

So about as much as the lost Ibrance growth (if Pallas holds and Penelope also fails)?

Pfizer, Mylan, Upjohn - so many moving parts.